HER3 differentiates basal from claudin type triple negative breast cancer and contributes to drug and microenvironmental induced resistance

Sinevici N, Ataeinia B, Zehnder V, Kevin Lin, Grove L, Heidari P, Umar Mahmood. HER3 differentiates basal from claudin type triple negative breast cancer and contributes to drug and microenvironmental induced resistance. Front Oncol. 2020 Nov 20;10:554704. doi: 10.3389/fonc.2020.554704. PMCID: PMC771503